Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shufeng Zhike granules in cough variant asthma (phase II)
CTR20192604Phase 2Active
- Sponsor
- Beijing Zhongyan Tongrentang Pharmaceutical Research and Development
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Shufeng Zhike Granules in cough variant asthma (CVA), sponsored by Beijing Zhongyan Tongrentang Pharmaceutical Research and Development. Started Apr 2020; status: active.
02
Drugs
Shufeng Zhike Granules
03
Conditions
cough variant asthma (CVA)
Beyond the preview
Go deeper on CTR20192604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192604.